
| Salt Composition: | Erlotinib (150mg) |
| Manufacturer: | Adley Formulations |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Erlotad 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlotad 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Erlotad 150 Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger EGFR, hence inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlotad 150 Tablet is to be taken empty stomach.
Alcohol
It is not known whether it is safe to consume alcohol with Erlotad 150 Tablet. Please consult your doctor.
Breastfeed
Erlotad 150 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Erlotad 150 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.